Corporate Corruption News ArticlesExcerpts of key news articles on corporate corruption
A video showing a mobile device snapping infrared images of an iPhone user is circulating around the internet. In the Tik Tok shared by user Brie Thomason, a digital camera using an infrared lens is seen filming an iPhone user observing their home screen. As the iPhone user stares blatantly at the device, Thomason's digital camera captures the iPhone snapping multiple infrared images every 5-10 seconds. While this discovery may cause some users to panic, Apple claims this is actually just an aspect of the iPhone that allows users to control their face ID and Animoji (the animated emoji function). According to Apple, this feature was first debuted as the iPhone X's most groundbreaking function; since it is not even discernible at first glance, even though it literally stares you in the face. The company calls this feature: the new TrueDepth IR camera. This camera, housed in the black notch at the top of the display, includes a number of high-tech components such as a "flood illuminator," infrared (IR) camera, and an infrared emitter. Officials say as an iPhone is used, the latter emits 30,000 infrared dots in a known pattern when a face is detected, enabling the iPhone X to generate a 3D map of a user's face. According to the team, this TrueDepth IR camera can also do this fast enough to support the creation of 3D motion data as well. So, yes, your iPhone is essentially taking "invisible" photos of you, but not for the reasons you would think.
Research Medical's owner, HCA Healthcare Inc., is a profitable, publicly traded network of 185 hospitals. Even in the year of Covid-19, 2020, the company generated $51.5 billion in revenue and increased its pretax earnings by 3.6 percent. That performance helped boost the total compensation HCA's chief executive, Samuel N. Hazen, received last year to $30.4 million, a 13 percent rise from 2019. The total worth of his compensation package equaled 556 times the compensation received by the median employee at HCA – $54,651. The figures highlight the growing CEO pay gap, a problem among many public companies according to some investors and workers and even a few CEOs. In 2019, for example, the average pay ratio among 350 large American companies was 320-to-1, according to research by the Economic Policy Institute. In 1989, the average was 61-to-1. Because [Jamelle] Brown, [an] emergency department worker, makes even less than the median, Hazen got roughly 1,000 times Brown's pay. Brown says he lives with his sister because he doesn't earn enough from his job at Research Medical to pay for his own apartment. HCA isn't alone in paying its chief executive vastly more than what rank-and-file workers earn. Acuity Brands, an industrial technology company, paid its CEO, Neil M. Ashe, $21 million last year, or 2,316 times the median employee's pay. Starbucks ... paid its CEO, Kevin Johnson, $14.7 million last year. That was 1,211 times the pay of its median employee.
Note: For more along these lines, see concise summaries of deeply revealing news articles on income inequality from reliable major media sources.
With few exceptions, big businesses are having a very different year from most of the country. Between April and September, one of the most tumultuous economic stretches in modern history, 45 of the 50 most valuable publicly traded U.S. companies turned a profit. Despite their success, at least 27 of the 50 largest firms held layoffs this year, collectively cutting more than 100,000 workers. Corporate leaders are touting their success and casting themselves as leaders on the road to economic recovery. Many of their firms have put Americans out of work and used their profits to increase the wealth of shareholders. 21 big firms that were profitable during the pandemic laid off workers anyway. Berkshire Hathaway raked in profits of $56 billion during the first six months of the pandemic while one of its subsidiary companies laid off more than 13,000 workers. Salesforce, Cisco Systems and PayPal cut staff even after their chief executives vowed not to do so. Companies sent thousands of employees packing while sending billions of dollars to shareholders. Walmart, whose CEO spent the past year championing the idea that businesses "should not just serve shareholders," nonetheless distributed more than $10 billion to its investors during the pandemic while laying off 1,200 corporate office employees. Economists estimate at least 100,000 small businesses permanently closed in the first two months of the pandemic alone.
Netflix’s brilliant new 90-minute docu-drama, The Social Dilemma ... might be the most important watch of recent years. The film, which debuted at Sundance Film Festival in January, takes a premise that’s unlikely to set the world alight ... ie that Facebook, Twitter, Instagram et al aren’t exactly creating a utopia. Its masterstroke is in recruiting the very Silicon Valley insiders that built these platforms to explain their terrifying pitfalls – which they’ve realised belatedly. You don’t get a much clearer statement of social media’s dangers than an ex-Facebook executive’s claim that: “In the shortest time horizon I’m most worried about civil war.” The commonly held belief that social media companies sell users’ data is quickly cast aside – the data is actually used to create a sophisticated psychological profile of you. What they’re selling is their ability to manipulate you, or as one interviewee puts it: “It’s the gradual, slight, imperceptible change in your own behaviour and perception. It’s the only thing for them to make money from: changing what you do, how you think, who you are.” Despite it being public knowledge that Vote Leave and Trump’s 2016 election campaign harvested voters’ Facebook data on a gigantic scale, The Social Dilemma still manages to find fresh and vital tales of how these platforms destabilise modern politics. Russia’s Facebook hack to influence the 2016 US election? “The Russians didn’t hack Facebook. They used the tools that Facebook made for legitimate advertisers,” laments one of the company’s ex-investors.
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday for remdesivir, and said the price would be $3,120 for patients with private insurance. The amount that patients pay out of pocket depends on insurance, income and other factors. The price was swiftly criticized; a consumer group called it “an outrage” because of the amount taxpayers invested toward the drug's development. In 127 poor or middle-income countries, Gilead is allowing generic makers to supply the drug; two countries are doing that for around $600 per treatment course. The drug, given through an IV, interferes with the coronavirus’s ability to copy its genetic material. In a U.S. government-led study, remdesivir shortened recovery time by 31% — 11 days on average versus 15 days for those given just usual care. Peter Maybarduk, a lawyer at the consumer group Public Citizen, called the price “an outrage.” “Remdesivir should be in the public domain” because the drug received at least $70 million in public funding toward its development, he said. “The price puts to rest any notion that drug companies will ‘do the right thing’ because it is a pandemic,” Dr. Peter Bach, a health policy expert ... said. “The price might have been fine if the company had demonstrated that the treatment saved lives. It didn’t.”
Note: The March coronavirus package passed in the U.S. "not only omitted language that would have limited drug makers’ intellectual property rights, it specifically prohibited the federal government from taking any action if it has concerns that the treatments or vaccines developed with public funds are priced too high." While many suffer economically from the virus, big Pharma is raking in big bucks. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption and the coronavirus from reliable major media sources.
The global insulin market is dominated by three companies: Eli Lilly, the French company Sanofi and the Danish firm Novo Nordisk. All three have raised list prices to similar levels. According to IBM Watson Health data, Sanofi’s popular insulin brand Lantus was $35 a vial when it was introduced in 2001; it’s now $270. Novo Nordisk’s Novolog was priced at $40 in 2001, and as of July 2018, it’s $289. The companies appear to have increased [prices] in lockstep over a number of years, prompting allegations of price fixing. All three companies denied these charges. (In 2010, Mexico fined Eli Lilly and three Mexican companies for price collusion on insulin, an allegation Eli Lilly also denied.) In the United States, a federal prosecutor and at least five state attorneys general are currently investigating the companies’ pricing practices. There is also another, less known corporate entity in the mix: pharmacy benefit managers (PBMs), which include Express Scripts, OptumRx and CVS Health; all are now named in lawsuits on high insulin prices. These corporate entities are powerful special interests. In 2017, the pharmaceutical and health product industry ... spent nearly $280 million on lobbying, the biggest spender by far of 20 top industries, according to the Center for Responsive Politics. The industry also has a revolving door to government. Alex Azar, the head of the Department of Health and Human Services, was the president of Eli Lilly’s U.S. division until 2017.
Note: For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical industry corruption from reliable major media sources.
Investment bankers have pressed health care companies on the front lines of fighting the novel coronavirus, including drug firms developing experimental treatments and medical supply firms, to consider ways that they can profit from the crisis. The largest voices in the health care industry stand to gain from billions of dollars in emergency spending on the pandemic, as do the bankers and investors who invest in health care companies. Over the past few weeks, investment bankers have been candid on investor calls and during health care conferences about the opportunity to raise drug prices. Executives joked about using the attention on Covid-19 to dodge public pressure on the opioid crisis. Health and Human Services Secretary Alex Azar previously served as president of the U.S. division of drug giant Eli Lilly and on the board of the Biotechnology Innovation Organization, a drug lobby group. During a congressional hearing ... Azar rejected the notion that any vaccine or treatment for Covid-19 should be set at an affordable price. "We can't control that price because we need the private sector to invest," said Azar. "The priority is to get vaccines and therapeutics. Price controls won't get us there." The initial $8.3 billion coronavirus spending bill passed in early March ... contained a provision that prevents the government from delaying the introduction of any new pharmaceutical to address the crisis over affordability concerns. The legislative text was shaped, according to reports, by industry lobbyists.
More than 12 million pounds of medically important antibiotics sold in this country are not for use in humans; they're for livestock. And the antibiotics are driving the spread of drug-resistant bacteria in the animals that can get passed on to us through food. Yet it's almost impossible to get on the farms to conduct inspections and stop infection outbreaks from spreading, even for public health officials. In 2015, Washington state epidemiologist Scott Lindquist investigated an outbreak of antibiotic resistant salmonella tied to roaster pigs. The salmonella was resistant to antibiotics. Lindquist traced the cause of the outbreak to a slaughterhouse. "We come in and we find the bacteria, essentially everywhere," [said Lindquist]. "So I want to go back to the farms and I wanna sample the pigs at the farm." But to his surprise, Lindquist, who was conducting the investigation, was flatly turned down. Thwarted, he says, by the National Pork Producers Council, the lead lobbying group for the $23 billion pork industry. They sent Lindquist a letter denying him access to the farms. Even federal inspectors have trouble getting on farms. They are not allowed on a farm to look for bacteria that make people sick without the farmer's permission. Farmers started using antibiotics decades ago ... to make animals grow faster with less food. In 2017, the Food and Drug Administration told farmers to stop using antibiotics in animals for growth purposes, but ... they are permitted to use them for disease prevention, and there are no reporting requirements.
Monsanto operated a “fusion center” to monitor and discredit journalists and activists, and targeted a reporter who wrote a critical book on the company, documents reveal. The records reviewed by the Guardian show Monsanto adopted a multi-pronged strategy to target Carey Gillam, a Reuters journalist who investigated the company’s weedkiller and its links to cancer. Monsanto, now owned by the German pharmaceutical corporation Bayer, also monitored a not-for-profit food research organization through its “intelligence fusion center”, a term that the FBI and other law enforcement agencies use for operations focused on surveillance and terrorism. The documents, mostly from 2015 to 2017, were disclosed as part of an ongoing court battle on the health hazards of the company’s Roundup weedkiller. Monsanto planned a series of “actions” to attack a book authored by Gillam prior to its release, including ... directing “industry and farmer customers” on how to post negative reviews. Monsanto paid Google to promote search results for “Monsanto Glyphosate Carey Gillam” that criticized her work. Monsanto “fusion center” officials wrote a lengthy report about singer Neil Young’s anti-Monsanto advocacy. The internal records don’t offer significant detail on the activities or scope of the fusion center, but ... government fusion centers have increasingly raised privacy concerns surrounding the way law enforcement agencies collect data, surveil citizens and share information.
For almost 17 years, states and counties around the country have conducted elections on machines that have been repeatedly shown to be vulnerable to hacking, errors and breakdowns, and that leave behind no proof that the votes counted actually match the votes that were cast. Now ... states and counties across the country are working to replace these outdated machines with new ones. The purchases replace machines from the turn of the century that raise serious security concerns. But the same companies that made and sold those machines are behind the new generation of technology, and a history of distrust between election security advocates and voting machine vendors has led to a bitter debate over the viability of the new voting equipment. The draw of the new machines, called ballot-marking devices (BMD), is the promise of a paper ballot. But there are concerns with the integrity of the paper trail a BMD would create at every stage. Many BMD models on the market print a sort of two-in-one ballot with one section to be read by machines and another to be read by humans. Barcodes – or QR codes – that represent a voter’s choices are printed on the ballot along with plain text showing, presumably, the same information in a way people can understand. When the ballot is scanned, it is the barcode that is scanned and counted, not the text that voters can read. If a barcode is printed that represents a different choice, or the scanners were hacked, voters would not know the difference.
Note: Computer scientists have shown nearly every make and model of electronic voting machine to be vulnerable to hacking. For more along these lines, see concise summaries of deeply revealing elections corruption news articles from reliable major media sources.
In October, when Ronan Farrow published his first article in The New Yorker on the alleged transgressions of Harvey Weinstein, people in the media and entertainment industries wondered how NBC had missed the story. After all, Mr. Farrow had spent months gathering material on the mogul when he was with NBC News. Now a producer who worked closely with Mr. Farrow has accused the network of putting a stop to the reporting, saying the order came from “the very highest levels of NBC.” Rich McHugh, the producer, who recently left his job in the investigative unit of NBC News, is the first person affiliated with NBC to publicly charge that the network impeded his and Mr. Farrow’s efforts to nail down the story of Mr. Weinstein’s alleged sexual misconduct. He called the network’s handling of the matter “a massive breach of journalistic integrity.” “Three days before Ronan and I were going to head to L.A. to interview a woman with a credible rape allegation against Harvey Weinstein, I was ordered to stop, not to interview this woman,” Mr. McHugh said. “And to stand down on the story altogether.” There was a point in our reporting where I felt there were obstacles to us reporting this externally, and there were obstacles to us reporting this internally,” the producer said. “Externally, I had Weinstein associates calling me repeatedly. I knew that Weinstein was calling NBC executives directly. One time it even happened when we were in the room.”
Note: NBC's chief executive stepped down amid sexual harassment claims 10 days after this article came out. For more along these lines, see concise summaries of deeply revealing news articles on media corruption and sexual abuse scandals.
CEOs at the 350 largest U.S. companies received 312 times as much in compensation as typical employees in 2017, according to a study released Thursday. The average chief executive received $18.9 million last year, a 17.6 percent increase from 2016, as the wages of a typical worker rose just 0.3 percent, according to research by the Economic Policy Institute, a Washington-based think tank. The highest CEO-to-worker pay ratio ever recorded is 344-to-1, in 2000. In 1965, it was 20-to-1. In 1989, it was 58-to-1. "CEO compensation has grown far faster than stock prices or corporate profits," EPI said in an online summary of the findings. "CEO compensation rose by 979 percent [based on stock options granted] or 1,070 percent [based on stock options realized] between 1978 and 2017. ... Higher CEO pay does not reflect correspondingly higher output or better firm performance. Exorbitant CEO pay therefore means that the fruits of economic growth are not going to ordinary workers."
Note: For more along these lines, see concise summaries of deeply revealing income inequality news articles from reliable major media sources.
Google wants to know where you go so badly that it records your movements even when you explicitly tell it not to. An Associated Press investigation found that many Google services on Android devices and iPhones store your location data even if you've used privacy settings that say they will prevent it from doing so. Computer-science researchers at Princeton confirmed these findings at the AP's request. Storing your minute-by-minute travels carries privacy risks. So the company will let you "pause" a setting called Location History. Google's support page on the subject states: "You can turn off Location History at any time. With Location History off, the places you go are no longer stored." That isn't true. Even with Location History paused, some Google apps automatically store time-stamped location data without asking. For example, Google stores a snapshot of where you are when you merely open its Maps app. And some searches that have nothing to do with location, like "chocolate chip cookies," or "kids science kits," pinpoint your precise latitude and longitude - accurate to the square foot - and save it to your Google account. Since 2014, Google has let advertisers track the effectiveness of online ads at driving foot traffic, a feature that Google has said relies on user location histories. The company is pushing further into such location-aware tracking to drive ad revenue, which rose 20 percent last year to $95.4 billion.
Note: This article instructs you how to effectively delete Google's tracking of your movements. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and the disappearance of privacy.
Just days after Google, Facebook and Apple purged videos and podcasts from the right-wing conspiracy site Infowars from their sites, the Infowars app has become one of the hottest in the country. On Wednesday, Infowars was the No. 1 overall “trending” app on the Google Play store. Among news apps, Infowars was No. 3 on Apple and No. 5 on Google, above all mainstream news organizations. The Infowars app, which includes news articles and the shows of the conspiracy theorist Alex Jones, had likely been downloaded a few hundred to a few thousand times a day on average after its introduction last month, said Randy Nelson ... at Sensor Tower, which tracks app data. Now, it is likely getting 30,000 to 40,000 downloads a day, Mr. Nelson estimated. “This is such a niche app with niche content, that for it to make that sort of jump means it has become very interesting to a much broader audience,” said Jonathan Kay, a co-founder of Apptopia, an app analytics firm. “Essentially, it’s gone from being niche to being mainstream.” Mr. Jones has achieved infamy and financial success for spreading lies. Many of his most outlandish claims are made during his show, which runs live for four hours each weekday and is streamed and rebroadcast across the internet. YouTube, Facebook, Spotify and Apple’s podcasts service were all important distribution points for the show.
Note: How many other conspiracy websites will be shut down for "spreading lies"? What happened to freedom of speech? Will the major media be shut down for "spreading lies" of it own? For more along these lines, see concise summaries of deeply revealing media manipulation news articles from reliable major sources.
One of the country’s largest voting machine makers has admitted in a letter to a U.S. senator that some of its past election-management systems had remote-access software preinstalled, despite past denials that any of its systems were equipped with such software. Election Systems and Software (ES&S) told Democratic Senator Ron Wyden ... that the company provided election equipment with remote connection software to an unspecified number of states from 2000 to 2006. “ES&S provided pcAnywhere remote connection software on the [Election-Management System] workstation to a small number of customers between 2000 and 2006,” wrote Tom Burt, ES&S president. The election-management system is used to count official election results and sometimes to program voting machines. PcAnywhere was the name of the remote-access software made by Symantec. In 2012, Symantec told all of its customers to disable or to uninstall the software after admitting it had been hacked in 2006, at the same time that ES&S was selling election-management systems with pcAnywhere preinstalled. ES&S would not say how many systems were sold with the software from 2000 to 2006 but stressed the company stopped using it in 2007, after it was prohibited by the Election Assistance Commission. A computer science professor at Carnegie Mellon University discovered in 2011 that the technology was pre-installed on an election-management system that was sold to a Pennsylvania county.
Note: For more on this threat to democracy, see this excellent essay. For more along these lines, see concise summaries of deeply revealing elections corruption news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Elections Information Center.
At the age of 46, DeWayne Johnson is not ready to die. But with cancer spread through most of his body, doctors say he probably has just months to live. Now Johnson, a husband and father of three in California, hopes to survive long enough to make Monsanto take the blame for his fate. Johnson will become the first person to take the global seed and chemical company to trial on allegations that it has spent decades hiding the cancer-causing dangers of its popular Roundup herbicide products – and his case has just received a major boost. Last week Judge Curtis Karnow issued an order clearing the way for jurors to consider not just scientific evidence related to what caused Johnson’s cancer, but allegations that Monsanto suppressed evidence of the risks of its weed killing products. “The internal correspondence noted by Johnson could support a jury finding that Monsanto has long been aware of the risk that its glyphosate-based herbicides are carcinogenic ... but has continuously sought to influence the scientific literature to prevent its internal concerns from reaching the public sphere and to bolster its defenses in products liability actions,” Karnow wrote. Johnson’s case ... is at the forefront of a legal fight against Monsanto. Some 4,000 plaintiffs have sued Monsanto alleging exposure to Roundup caused them, or their loved ones, to develop non-Hodgkin lymphoma (NHL).
Note: As major lawsuits like this one against Monsanto begin to unfold, the EPA continues to use industry studies to declare Roundup safe while ignoring independent scientists. A recent independent study published in a scientific journal found a link between glyphosate and gluten intolerance. Internal FDA emails suggest that the food supply contains far more glyphosate than government reports indicate. For more along these lines, see concise summaries of deeply revealing news articles on food system corruption and health.
[Here's] how much of your information ... Facebook and Google store about you. Google stores your location ... every time you turn on your phone. You can see a timeline of where you’ve been from the very first day you started using Google on your phone. Google stores search history across all your devices. Even if you delete your search history and phone history on one device, it may still have data saved from other devices. Google creates an advertisement profile based on your information, including your location, gender, age, hobbies, career, interests, relationship status, possible weight ... and income. Google offers an option to download all of the data it stores about you. I’ve requested to download it and the file is 5.5GB big, which is roughly 3m Word documents. Facebook offers a similar option to download all your information. Mine was roughly 600MB, which is roughly 400,000 Word documents. Facebook also stores what it thinks you might be interested in based off the things you’ve liked and what you and your friends talk about. The data they collect includes tracking where you are, what applications you have installed, when you use them, what you use them for, access to your webcam and microphone at any time, your contacts, your emails, your calendar, your call history, the messages you send and receive, the files you download, the games you play, your photos and videos, your music, your search history, your browsing history, even what radio stations you listen to.
Sitting in a hotel bar, Alexander Nix, who runs the political data firm Cambridge Analytica, had a few ideas for a prospective client looking for help in a foreign election. The firm could send an attractive woman to seduce a rival candidate and secretly videotape the encounter, Mr. Nix said, or send someone posing as a wealthy land developer to pass a bribe. “We have a long history of working behind the scenes,” Mr. Nix said. The prospective client, though, was actually a reporter. The encounter was secretly filmed as part of a monthslong investigation into Cambridge Analytica, the data firm with ties to President Trump’s 2016 campaign. The results of Channel 4’s work were broadcast ... days after reports ... that the firm had harvested the data from more than 50 million Facebook profiles in its bid to develop techniques for predicting the behavior of individual American voters. Less noticed has been the work that Cambridge Analytica and its parent company, the SCL Group, have done outside the United States. “Many of our clients don’t want to be seen to be working with a foreign company,” he told the Channel 4 reporter. “We can set up fake IDs and websites.” Mr. Nix ... boasted that Cambridge Analytica employs front companies and former spies on behalf of political clients. The information that is uncovered ... is then put “into the bloodstream to the internet,” said Mark Turnbull, another Cambridge executive. “Then watch it grow,” he added. “It has to happen without anyone thinking, ‘That’s propaganda.’”
Note: Watch an astounding video revealing how Cambridge Analytica has successfully manipulated national elections around the world using sleazy tactics like pretty women to entrap candidates and offering major bribes while recording the exchange. And here is a video featuring the whistleblower who exposed this.
A reputable-sounding nonprofit organization released a report attacking the organic food industry in April 2014. The 30-page report by Academics Review, described as “a non-profit led by independent academic experts in agriculture and food sciences,” found that consumers were being duped into spending more money for organic food. The [group's] press release ends on this note: “Academics Review has no conflicts-of-interest associated with this publication, and all associated costs for which were paid for using our general funds without any specific donor’ influence or direction.” What was not mentioned in the report, the news release or on the website: Executives for Monsanto Co., the world’s leading purveyor of agrichemicals and genetically engineered seeds, along with key Monsanto allies, engaged in fund raising for Academics Review, collaborated on strategy and even discussed plans to hide industry funding, according to emails obtained by U.S. Right to Know. Jay Byrne, former head of communications at Monsanto ... offered to act as a “commercial vehicle” to help find corporate funding for Academics Review. In March 2016, Monica Eng reported ... on documents showing that Monsanto paid Professor Bruce Chassy more than $57,000 over a 23-month period to travel, write and speak about GMOs - money that was not disclosed to the public. The money was part of at least $5.1 million in undisclosed money Monsanto sent through the University of Illinois Foundation.
Note: Monsanto has reportedly pushed fake science in other circumstances as well. Major lawsuits are beginning to unfold over Monsanto's lies to regulators and the public on the dangers of its products, most notably Roundup. Yet the EPA continues to use industry studies to declare Roundup safe while ignoring independent scientists. For more along these lines, see concise summaries of deeply revealing news articles on food system corruption and health.
Regulators have approved the first drug with a sensor that alerts doctors when the medication has been taken. The digital pill combines two existing products: the former blockbuster psychiatric medication Abilify - long used to treat schizophrenia and bipolar disorder - with a sensor tracking system first approved in 2012. Experts say the technology could be a useful tool, but it will also change how doctors relate to their patients as they’re able to see whether they are following instructions. The pill has not yet been shown to actually improve patients’ medication compliance, a feature insurers are likely to insist on before paying for the pill. Additionally, patients must be willing to allow their doctors and caregivers to access the digital information. The technology carries risks for patient privacy, too, if there are breaches of medical data or unauthorized use as a surveillance tool, said James Giordano, a professor of neurology at Georgetown University Medical Center. “Could this type of device be used for real-time surveillance? The answer is of course it could,” said Giordano. The new pill, Abilify MyCite, is embedded with a digital sensor that is activated by stomach fluids, sending a signal to a patch worn by the patient and notifying a digital smartphone app that the medication has been taken.
Note: In 2010, it was quietly reported that Novartis AG would be seeking regulatory approval for such "chip-in-a-pill technology". For more along these lines, see concise summaries of deeply revealing news articles on microchip implants and the disappearance of privacy.
Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.